N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9382228
APP PUB NO 20140275080A1
SERIAL NO

14214185

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described are compounds of Formula I

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DECIPHERA PHARMACEUTICALS LLC200 SMITH STREET WALTHAM MA 02451

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Caldwell, Timothy Malcolm Fishers, US 7 282
Flynn, Daniel L Lawrence, US 173 4670
Kaufman, Michael D Lawrence, US 71 1964
Patt, William C Lawrence, US 23 609
Samarakoon, Thiwanka Quincy, US 17 199
Vogeti, Lakshminarayana Arlington, US 27 425
Yates, Karen M Fishers, US 3 96

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 5, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00